Ishihara Sangyo Kaisha,Ltd.
Stock Price Chart
2026/04/13 UpdatedPrice Trend
2026/04/13 UpdatedPrice & Trading Details
2026/04/13 UpdatedPRICE
TRADING
Analyst Recommendations 4 analysts
Updated 2026/01/11Shareholder Composition
Updated 2026/01/11Dividend History
Updated 2026/04/12| Year | Dividend | Change |
|---|---|---|
| 2026 | ¥90 | -21.7% |
| 2025 | ¥115 | +64.3% |
| 2024 | ¥70 | +66.7% |
| 2023 | ¥42 | +16.7% |
| 2022 | ¥36 | - |
Financial Performance
2026/04/12 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥110,955M | ¥131,238M | ¥138,456M | ¥145,196M |
| Gross Profit | ¥32,657M | ¥33,265M | ¥37,101M | ¥39,531M |
| Operating Income | ¥11,557M | ¥8,632M | ¥11,492M | ¥10,483M |
| Pretax Income | ¥13,630M | ¥9,980M | ¥10,137M | ¥11,565M |
| Net Income | ¥11,690M | ¥6,947M | ¥7,988M | ¥8,410M |
| EPS | ¥292.58 | ¥175.75 | ¥209.27 | ¥219.98 |
| Operating Margin | 10.42% | 6.58% | 8.30% | 7.22% |
| Balance Sheet | ||||
| Total Assets | ¥185,758M | ¥201,913M | ¥224,324M | ¥225,097M |
| Total Equity | ¥91,869M | ¥97,430M | ¥106,067M | ¥114,272M |
| Total Liabilities | ¥93,889M | ¥104,483M | ¥118,257M | ¥110,825M |
| Cash | ¥27,073M | ¥17,662M | ¥19,982M | ¥24,948M |
| Interest-bearing Debt | ¥46,825M | ¥52,919M | ¥66,913M | ¥68,941M |
| Equity Ratio | 49.46% | 48.25% | 47.28% | 50.77% |
| D/E Ratio | 0.51 | 0.54 | 0.63 | 0.60 |
| Cash Flow | ||||
| Operating CF | ¥16,501M | -¥6,022M | -¥2,811M | ¥18,332M |
| Investing CF | -¥4,319M | -¥5,021M | -¥7,044M | -¥11,412M |
| Financing CF | -¥11,601M | ¥1,048M | ¥11,524M | -¥2,337M |
| Free CF | ¥16,501M | -¥6,022M | -¥2,811M | ¥18,332M |
| Efficiency | ||||
| ROE | 12.72% | 7.13% | 7.53% | 7.36% |
| ROA | 6.29% | 3.44% | 3.56% | 3.74% |
Latest IR Information
-
Q3 Financial Summary for the Fiscal Year Ending March 2026 [Japanese GAAP] (Consolidated)
For Q3 of the fiscal year ending March 2026, net sales were 108.072 billion yen (2.5% YoY increase), operating income was 11.089 billion yen (189.2% YoY increase), and net income attributable to owners of parent for the quarter was 9.606...
Read more -
Notice Regarding Revision of Full-Year Consolidated Earnings Guidance and Dividend Forecast for the Fiscal Year Ending March 2026 (Dividend Increase)
The full-year consolidated earnings guidance for the fiscal year ending March 2026 has been upwardly revised to net sales of 154,500 hundred million yen (up 1.6% from the previous forecast), operating income of 17,000 hundred million yen (up 6.3%), and...
Read more
Latest News (5 items)
-
Average Analyst Rating: none
Average Target Price: ¥2,190
Rating Score: - (Based on 4 analysts)
※1=Strong Buy, 5=Strong Sell
Company Information
About
Ishihara Sangyo Kaisha,Ltd. manufactures and sells organic and inorganic chemicals in Japan, Asia, the United States, Europe, and internationally. It offers titanium dioxide (TiO2) products under the TIPAQUE trade name, which includes white pigments for applications in paints, inks, plastics, cosmetics, and other products; yellow pigments; and functional materials, such as ultrafine TiO2, ultrafine ZnO, electro-conductive materials, photocatalytic TiO2, high purity TiO2, titanium tetrachride, TiO2 for catalytic use, and acicular type TiO2. The company also offers matting agents; heat shield materials; and environmental products, such as gypsum-based neutral soil adjustment agents, heavy metal absorbers and insolubilizers, iron oxide-based VOCs decomposers, and related combined solutions. In addition, the company provides agrochemicals, including herbicides, fungicides, insecticides, and nematicides; animal healthcare products comprising fuzapladib sodium hydrate, an anti-pancreatitis drug for dogs; and organic intermediates, such as CF3-pyridine compounds offered as pharmaceutical raw materials. Ishihara Sangyo Kaisha,Ltd. was founded in 1920 and is headquartered in Osaka, Japan.